Robert E. Hoffman's Net Worth
$1.7 Million
Who is Robert E. Hoffman?
Robert E. Hoffman has an estimated net worth of $1.7 Million. This is based on reported shares across multiple companies, which include ARENA PHARMACEUTICALS INC, INNOVUS PHARMACEUTICALS, INC., CombiMatrix Corp, Kura Oncology, Inc., HERON THERAPEUTICS, INC. /DE/, Kintara Therapeutics, Inc., Aravive, Inc., and MABVAX THERAPEUTICS HOLDINGS, INC..
SEC CIK
Robert E. Hoffman's CIK is 0001166288
Past Insider Trading and Trends
2019 was Robert E. Hoffman's most active year for acquiring shares with 9 total transactions. Robert E. Hoffman's most active month to acquire stocks was the month of November. 2008 was Robert E. Hoffman's most active year for disposing of shares, totalling 6 transactions. Robert E. Hoffman's most active month to dispose stocks was the month of June. 2016 saw Robert E. Hoffman paying a total of $730,712.50 for 2,565,517 shares, this is the most they've acquired in one year. In 2018 Robert E. Hoffman cashed out on 60,000 shares for a total of $1,145,230.32, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ARENA PHARMACEUTICALS INC No price found
SVP, Finance and CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +34.82% | 15K |
—
|
—
| 58.07K |
Dec 15
| |||
Form 4
| +96.06% | 20K |
—
|
—
| 40.82K |
Dec 17
| |||
Form 4
|
—
|
0
|
$5.01 | -$456,163.88 | 19.57K |
Scheduled
|
Apr 1
| ||
Form 4
| +443.52% | 15K |
—
|
—
| 18.38K |
Dec 13
| |||
Form 4
|
—
|
0
|
$4.90 | -$341,980.00 | 3.38K |
Scheduled
|
Oct 1
| ||
Form 4
| -78.35% | -10.00K |
$11.00 | -$110,000.00 | 2.76K |
Jul 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 19
| |||
Form 4
|
—
|
0
|
$1.64 | $0.88 | 12.14K |
Jan 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 17
| |||
Form 4
| -14.87% | -10.00K |
$6.16 | -$61,605.00 | 57.25K |
Scheduled
|
Sep 2
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 3
| |||
Form 4
| -1.04% | -700.00 |
—
|
—
| 66.54K |
Feb 13
| |||
Form 4
| -1.76% | -1.20K |
—
|
—
| 67.04K |
Jul 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 26
| |||
Form 4
| -3.61% | -2.50K |
$5.53 | -$75,475.00 | 66.71K |
Jul 31
| |||
Form 4
| +0.92% | 625 |
$3.75 | $2,343.75 | 68.62K |
Mar 31
| |||
Form 4
| +28.30% | 15K |
—
|
—
| 68K |
Jan 20
| |||
Form 4
| +0.61% | 320 |
$3.75 | $1,200.00 | 53K |
Dec 30
| |||
Form 4
| -0.38% | -200.00 |
—
|
—
| 52.68K |
Dec 7
| |||
Form 4
| +0.42% | 223 |
$3.75 | $836.25 | 52.88K |
Sep 30
| |||
Form 4
| +0.27% | 140 |
$3.75 | $525.00 | 52.65K |
Jun 30
| |||
Form 4
| +0.70% | 367 |
$3.75 | $1,376.25 | 52.51K |
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 4
| +0.24% | 127 |
$3.75 | $476.25 | 52.15K |
Dec 31
| |||
Form 4
| +0.29% | 150 |
$3.66 | $549.00 | 52.02K |
Sep 30
| |||
Form 4
| +0.20% | 103 |
$4.64 | $477.92 | 51.87K |
Jun 30
| |||
Form 4
| +0.21% | 108 |
$5.45 | $588.60 | 51.77K |
Mar 31
| |||
Form 4
| -0.39% | -200.00 |
—
|
—
| 51.66K |
Jan 18 - Jan 21
| |||
Form 4
| +0.14% | 74 |
$5.10 | $377.40 | 51.86K |
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INNOVUS PHARMACEUTICALS, INC. No price found
CHIEF FINANCIAL OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CombiMatrix Corp No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -8.62K |
—
|
—
|
0
|
Nov 14
| |||
Form 4
| +207.56% | 5K |
$3.19 | $15,962.50 | 7.41K |
May 10
| |||
Form 4
| +29.99% | 12.53K |
—
|
—
| 54.3K |
Jan 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
| +72.08% | 17.5K |
—
|
—
| 41.77K |
Feb 20
| |||
Form 4
|
∞
| 24.27K |
—
|
—
| 24.27K |
Dec 19 - Dec 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kura Oncology, Inc. (KURA) Snapshot price: $20.48
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HERON THERAPEUTICS, INC. /DE/ (HRTX) Snapshot price: $2.32
CFO & SVP, Finance
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
| +138.81% | 744 |
$26.71 | -$676,396.50 | 1.28K |
Scheduled
|
Apr 30 - Jul 2
| ||
Form 4
|
∞
| 536 |
$13.05 | $6,993.46 | 536 |
Oct 31 - Dec 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||